Clinical Trials on Breast Lobular Carcinoma In Situ in Belgium

Total 1278 results

XEOS Medical

Recruiting

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer (BrIMA)

Breast Cancer | Breast Cancer Invasive | Breast Cancer in Situ

Belgium
Trans Tasman Radiation Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical... and other collaborators

Active, not recruiting

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast (DCIS)

Carcinoma, Ductal, Breast

United Kingdom, Netherlands, Ireland, Switzerland, Australia, Singapore, New Zealand, Belgium, Canada, Italy, France
Jules Bordet Institute
Hoffmann-La Roche

Recruiting

Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) (ROSALINE)

HER2-negative Breast Cancer | ER+ Breast Cancer | Invasive Lobular Breast Carcinoma

Belgium, France
Cytori Therapeutics

Completed

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy (RESTORE-2)

Breast Neoplasms | Carcinoma, Ductal, Breast | Mammaplasty | Mastectomy, Segmental, Lumpectomy, Breast Reconstruction,

Spain, United Kingdom, Belgium, Italy
Queen Mary University of London
Cancer Research UK

Completed

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ (IBIS-II DCIS)

Breast Cancer

France, Switzerland, Ireland, United Kingdom, Italy, Australia, Austria, Belgium, Chile, Germany, Hungary, Malta, Sweden, Turkey
Cliniques universitaires Saint-Luc- Université...

Completed

Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer

Early Stage Breast Carcinoma

Belgium
Jules Bordet Institute

Completed

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

Carcinoma Breast Stage IV

Belgium
G1 Therapeutics, Inc.

Completed

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer Female

United States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
University Hospital, Ghent

Completed

Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy

Breast Carcinoma

Belgium
Novartis Pharmaceuticals

Terminated

Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)

Belgium, Australia, United States
University Hospital, Ghent
National Cancer Plan, France

Completed

Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis

Breast Carcinoma

Belgium
Universitair Ziekenhuis Brussel
Vrije Universiteit Brussel; Fund for Scientific Research, Flanders, Belgium

Active, not recruiting

The Effect of Pain Neuroscience Education and Behavioural Graded Activity on Chronic Pain in Breast Cancer Survivors (BCS-PAIN)

Breast Neoplasms | Chronic Pain | Survivors

Belgium
Jules Bordet Institute

Completed

Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients (IJBMNZrT003)

Breast Neoplasms | Secondary | HER2 Positive Carcinoma of Breast

Belgium
Jules Bordet Institute

Completed

Double-blind Study to Assess effectIveness of Pectoral Nerves Block After Breast Surgery on Piritramide Consumption (DESIGN)

Locoregional Analgesia in Breast Surgery

Belgium
Jean François Brichant

Enrolling by invitation

Transfer of Non-technical Skills From Simulation to Clinical Practice

in Situ Simulation

Belgium
Universiteit Antwerpen
University Hospital, Antwerp; Fund for Scientific Research, Flanders, Belgium

Recruiting

Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment. (sCANsens)

Chronic Pain | Neoplasm, Breast | Carcinoma Breast

Belgium
Mithra Pharmaceuticals

Completed

Safety and Tolerability of Cidofovir Gel Applied on Cervix Squamous Lesions

Uterine Cervical Neoplasms | Cervix Intraepithelial Neoplasia

Belgium
Mithra Pharmaceuticals

Completed

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3) (Colvir-PhaseII)

Cervix Intraepithelial Neoplasia | Uterine Cervical Neoplasia

Belgium
University Hospital, Ghent

Recruiting

HOBBIT 3: Mental Exercises and Temporal Alteration (HOBBIT-META)

Breast Neoplasm | Radiotherapy | Breath Holding | Mental Test

Belgium
Universiteit Antwerpen
Amsterdam UMC, location VUmc; Novosanis NV; Self-screen B.V.

Completed

CASUS: Improved and Quality Assured Collection of First-void Urine (CASUS-WP1)

Cervical Cancer | Cervical Intraepithelial Neoplasia | HPV-Related Cervical Carcinoma | Urine | Human Papilloma Virus

Belgium
Catherine Vanpachterbeke

Completed

Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions

High-Grade Squamous Intraepithelial Lesions

Belgium
Brugmann University Hospital

Completed

A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.

High Grade Cervical Epithelial Neoplasia (CIN2+)

Belgium
Jhpiego
Jawaharlal Nehru Medical College

Completed

Performance, Safety, and Efficacy of a New Cryotherapy Device for Cervical Dysplasia [Part II] (CryoPop)

Cervical Dysplasia

India
Immutep S.A.S.

Recruiting

Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy (AIPAC-003)

Breast Carcinoma

Spain, United States, Belgium
Marc Arbyn
University Hospital, Ghent; Universitair Ziekenhuis Brussel; University Hospital... and other collaborators

Active, not recruiting

Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples (VALHUDES)

Cervical Intraepithelial Neoplasia Grade 2/3

Belgium
Universiteit Antwerpen
Amsterdam UMC, location VUmc; Novosanis NV; Self-screen B.V.

Completed

CASUS: Validation for Detection of Precursor Lesions (CASUS-WP4)

Cervical Cancer | Cervical Intraepithelial Neoplasia | HPV-Related Cervical Carcinoma | Urine | Human Papilloma Virus

Belgium
Jules Bordet Institute

Completed

ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue. (EC2075)

Breast Cancer.

Belgium
Jules Bordet Institute

Completed

Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

Invasive Breast Cancer

Belgium
Jules Bordet Institute

Recruiting

PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer. (PRISMA)

TNBC - Triple-Negative Breast Cancer

Belgium
University of Liege

Completed

Feasibility and Impact of Group Interventions on Breast Cancer Patients Well-being (GIBC)

Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Age-related Changes in the Immune System and Their Impact on Elderly Breast Cancer (IMAGE)

Breast Cancer

Belgium
Jules Bordet Institute
Centre Hospitalier Universitaire de Tivoli; Hôpital de Braine-l'Alleud; Clinique... and other collaborators

Completed

Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients

Breast Cancer

Belgium
Pierre Fabre Medicament
Iqvia Pty Ltd

Recruiting

A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib (NEAR)

Breast Cancer | HER2-positive Breast Cancer | Adjuvant Therapy

Belgium
Jules Bordet Institute

Recruiting

ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study (BREASTIFLU-1)

Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer (RibOB)

Breast Cancer

Belgium
Jules Bordet Institute

Completed

Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy

Breast Cancer

Belgium
Jules Bordet Institute

Completed

Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer (EndoTAG-1)

Breast Cancer

Belgium
University Hospital, Ghent

Not yet recruiting

FAST-FORWARD vs HAI5

Cancer, Breast

Belgium
Cliniques universitaires Saint-Luc- Université...
Jules Bordet Institute

Recruiting

A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors (CICLIBIOME)

Breast Cancer

Belgium
KU Leuven
Universitaire Ziekenhuizen KU Leuven; Vrije Universiteit Brussel

Recruiting

Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity (UPLIFT-BC)

Breast Cancer

Belgium
KU Leuven
Universitaire Ziekenhuizen KU Leuven; Vrije Universiteit Brussel

Recruiting

Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment (UPLIFT-BC)

Breast Cancer

Belgium
Brugmann University Hospital

Completed

Monitoring of Breast Cancers Treated by Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging

Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

The Added Value of a Third Supervised Training Session to a Standard 12-week Rehabilitation Program After Breast Cancer: Pilot Study

Breast Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Development of a Response Signature to Neoadjuvant Chemotherapy for Breast Cancer (Breast-sign)

Breast Cancer

Belgium
Brugmann University Hospital

Withdrawn

Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound.

Breast Cancer

Belgium
Université Libre de Bruxelles
Jules Bordet Institute

Completed

Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment

Breast Cancer

Belgium
Neovii Biotech

Terminated

Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer (IV REXBC 02)

Breast Cancer | Breast Neoplasms

Belgium
Universitaire Ziekenhuizen KU Leuven
St-Augustinus Wilrijk

Completed

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women

Breast Cancer

Belgium
University Hospital, Ghent

Completed

Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer (HAI-5)

Breast Cancer | Radiotherapy

Belgium

Clinical Trials on Breast Lobular Carcinoma In Situ in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations